Browse 26479 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| March 21st, 2019 |
Support for Small Business Innovation Research to Develop New Open and Closed-Loop Automated Technologies for Better Type 1 Diabetes Therapy and Monitoring (SBIR) (R43/R44 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 23rd, 2019 |
Promoting Reductions in Intersectional StigMa (PRISM) to Improve the HIV Prevention Continuum (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 23rd, 2019 |
Promoting Reductions in Intersectional StigMa (PRISM) to Improve the HIV Prevention Continuum (R34 Clinical Trial Required) |
National Institutes of Health |
| January 23rd, 2019 |
Promoting Reductions in Intersectional StigMa (PRISM) to Improve the HIV Prevention Continuum (R21 Clinical Trial Optional) |
National Institutes of Health |
| January 8th, 2019 |
Improved Health and Nutrition Activity |
Guatemala USAID Guatemala City |
| March 13th, 2019 |
Long-acting Drug Delivery Systems for ART Optimization in HIV-1 Infected Children (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2022 |
Telomeres in Wellness and Disease: A Biobehavioral Approach (R21 Clinical Trial Optional) |
National Institutes of Health |
| July 30th, 2021 |
Data Science Research: Personal Health Libraries for Consumers and Patients (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2022 |
Telomeres in Wellness and Disease: A Biobehavioral Approach (R01 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2019 |
Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed) |
National Institutes of Health |
| November 12th, 2021 |
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 12th, 2021 |
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) |
National Institutes of Health |
| March 13th, 2019 |
Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 19th, 2019 |
Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 11th, 2019 |
Implementation Science for Cancer Control: Advanced Centers (P50 Clinical Trial Optional) |
National Institutes of Health |
| February 11th, 2019 |
Implementation Science for Cancer Control: Developing Centers (P50 Clinical Trial Optional) |
National Institutes of Health |
| February 11th, 2019 |
Medications Development for the Treatment of Alcohol Use Disorder (U01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2022 |
Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| December 17th, 2018 |
PEPFAR Uganda Community Grants to Combat HIV/AIDS |
US Mission to Uganda |
| January 15th, 2019 |
Geriatrics Academic Career Award Program |
Health Resources and Services Administration |
|
| January 7th, 2022 |
Medical Simulators for Practicing Patient Care Providers Skill Acquisition, Outcomes Assessment and Technology Development (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 13th, 2019 |
Single-Cell Multi-Omics of HIV Persistence (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| May 3rd, 2019 |
Public Health Emergency Preparedness (PHEP) Cooperative Agreement |
Centers for Disease Control OPHPR |
| January 7th, 2022 |
Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2022 |
Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 4th, 2019 |
U.S. Ambassador's PEPFAR Small Grants Program 2018-2019 |
US Mission to Malawi |
| September 5th, 2021 |
Investigator Initiated Research in Computational Genomics and Data Science (R43/R44 Clinical Trial Not Allowed) |
National Institutes of Health |
| December 24th, 2018 |
USAID/Ethiopia: Health Workforce Improvement Program |
Ethiopia USAID Addis Ababa |
| February 6th, 2019 |
Geriatrics Workforce Enhancement Program |
Health Resources and Services Administration |
| November 8th, 2021 |
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) |
National Institutes of Health |
| April 15th, 2019 |
Performing Regulatory-Required Medical Examinations for U.S. Bound Populations by US Screening Physicians |
Centers for Disease Control NCEZID |
| January 7th, 2022 |
NINR Clinical Trial Planning Grant (R34 Clinical Trial Required) |
National Institutes of Health |
| January 23rd, 2019 |
Data Coordinating Center for the Diabetic Foot Consortium (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
| December 13th, 2019 |
Global Noncommunicable Diseases and Injury Across the Lifespan: Exploratory Research (R21 Clinical Trials Optional) |
National Institutes of Health |
| March 4th, 2019 |
Advancing Infectious Disease Detection and Response in Liberia |
Centers for Disease Control and Prevention ERA |
| April 30th, 2019 |
Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients |
Centers for Disease Control NCCDPHP |
| April 15th, 2019 |
The CDC Cancer Genomics Program: Translating Research into Public Health Practice |
Centers for Disease Control NCCDPHP |
| May 10th, 2019 |
2019 Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC) |
Centers for Disease Control NCEZID |
| January 7th, 2022 |
Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2022 |
Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R21 Clinical Trial Optional) |
National Institutes of Health |
